LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 184

Search options

  1. Article ; Online: Your results may vary: the imprecision of medical measurements.

    McCormack, James P / Holmes, Daniel T

    BMJ (Clinical research ed.)

    2020  Volume 368, Page(s) m149

    MeSH term(s) Adaptor Proteins, Vesicular Transport/blood ; Biomarkers/metabolism ; Bone Density/drug effects ; Bone Density Conservation Agents/pharmacology ; Clinical Laboratory Techniques/standards ; Diabetes Mellitus, Type 2/diagnosis ; Diagnostic Errors ; Diagnostic Tests, Routine/standards ; Diphosphonates/pharmacology ; Drug Monitoring/methods ; Glycated Hemoglobin A/metabolism ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use ; Reproducibility of Results ; Uncertainty
    Chemical Substances Adaptor Proteins, Vesicular Transport ; Biomarkers ; Bone Density Conservation Agents ; Diphosphonates ; Glycated Hemoglobin A ; Hydroxymethylglutaryl-CoA Reductase Inhibitors ; hemoglobin A1c protein, human ; COG2 protein, human (160124-07-2)
    Language English
    Publishing date 2020-02-20
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 1362901-3
    ISSN 1756-1833 ; 0959-8154 ; 0959-8146 ; 0959-8138 ; 0959-535X ; 1759-2151
    ISSN (online) 1756-1833
    ISSN 0959-8154 ; 0959-8146 ; 0959-8138 ; 0959-535X ; 1759-2151
    DOI 10.1136/bmj.m149
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Sponge-derived fatty acids inhibit biofilm formation of MRSA and MSSA by down-regulating biofilm-related genes specific to each pathogen.

    Khan, Neyaz A / Barthes, Nicolas / McCormack, Grace / O'Gara, James P / Thomas, Olivier P / Boyd, Aoife

    Journal of applied microbiology

    2023  Volume 134, Issue 8

    Abstract: Aim: A promising approach for the development of next-generation antimicrobials is to shift their target from causing bacterial death to inhibiting virulence. Marine sponges are an excellent potential source of bioactive anti-virulence molecules (AVM). ... ...

    Abstract Aim: A promising approach for the development of next-generation antimicrobials is to shift their target from causing bacterial death to inhibiting virulence. Marine sponges are an excellent potential source of bioactive anti-virulence molecules (AVM). We screened fractions prepared from 26 samples of Irish coastal sponges for anti-biofilm activity against clinically relevant pathogens.
    Methods and results: Fifteen fractions from eight sponge species inhibited biofilm of methicillin-susceptible Staphylococcus aureus (MSSA), methicillin-resistant S. aureus (MRSA), and/or Listeria monocytogenes without causing growth inhibition. Gas chromatograph/mass spectroscopy analyses of Mycale contarenii fractions revealed the presence of myristic acid and oleic acid. These fatty acids repressed transcription of the fibronectin-binding protein fnbA and fnbB genes and the polysaccharide intercellular adhesin icaADBC operon, which are required for MRSA and MSSA biofilm formation, respectively.
    Conclusions: This study illustrates the potential of AVM from Irish coastal sponges to specifically target bacterial virulence phenotypes, in this case, repression of biofilm formation via decreased transcription of biofilm-associated genes in MSSA and MRSA.
    MeSH term(s) Animals ; Methicillin Resistance ; Methicillin-Resistant Staphylococcus aureus/genetics ; Anti-Bacterial Agents/pharmacology ; Porifera ; Fatty Acids/pharmacology ; Staphylococcal Infections/microbiology ; Staphylococcus aureus ; Biofilms ; Microbial Sensitivity Tests
    Chemical Substances Anti-Bacterial Agents ; Fatty Acids
    Language English
    Publishing date 2023-06-01
    Publishing country England
    Document type Journal Article
    ZDB-ID 1358023-1
    ISSN 1365-2672 ; 1364-5072
    ISSN (online) 1365-2672
    ISSN 1364-5072
    DOI 10.1093/jambio/lxad152
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: The endurance of medication overload: Rethinking the medication review process.

    McCormack, James P / Brownlee, Shannon / Garber, Judith / Devlin, John W

    Journal of the American College of Clinical Pharmacy : JACCP

    2020  Volume 3, Issue 2, Page(s) 396–397

    Language English
    Publishing date 2020-03-09
    Publishing country United States
    Document type Journal Article
    ISSN 2574-9870
    ISSN (online) 2574-9870
    DOI 10.1002/jac5.1150
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Adult hypertension referral pathway and therapeutic management: British and Irish Hypertension Society position statement.

    Lewis, Philip / George, Jacob / Kapil, Vikas / Poulter, Neil R / Partridge, Sarah / Goodman, James / Faconti, Luca / McCormack, Terry / Wilkinson, Ian B

    Journal of human hypertension

    2024  Volume 38, Issue 1, Page(s) 3–7

    Abstract: In the UK, most adults with hypertension are managed in Primary Care. Referrals to Secondary Care Hypertension Specialists are targeted to patients in whom further investigations are likely to change management decisions. In this position statement the ... ...

    Abstract In the UK, most adults with hypertension are managed in Primary Care. Referrals to Secondary Care Hypertension Specialists are targeted to patients in whom further investigations are likely to change management decisions. In this position statement the British and Irish Hypertension Society provide clinicians with a framework for referring patients to Hypertension Specialists. Additional therapeutic advice is provided to optimise patient management whilst awaiting specialist review. Our aim is to ensure that referral criteria to Hypertension Specialists are consistent across the UK and Ireland to ensure equitable access for all patients.
    MeSH term(s) Adult ; Humans ; Hypertension/diagnosis ; Hypertension/therapy ; Ireland ; Referral and Consultation ; White People ; United Kingdom
    Language English
    Publishing date 2024-01-09
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 639472-3
    ISSN 1476-5527 ; 0950-9240
    ISSN (online) 1476-5527
    ISSN 0950-9240
    DOI 10.1038/s41371-023-00882-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: No evidence base for monitoring aminoglycoside levels.

    McCormack, James P

    BMJ (Clinical research ed.)

    2012  Volume 345, Page(s) e7264; author reply e7265

    MeSH term(s) Aminoglycosides/blood ; Anti-Bacterial Agents/blood ; Drug Monitoring/methods ; Female ; Humans
    Chemical Substances Aminoglycosides ; Anti-Bacterial Agents
    Language English
    Publishing date 2012-10-30
    Publishing country England
    Document type Comment ; Letter
    ZDB-ID 1362901-3
    ISSN 1756-1833 ; 0959-8154 ; 0959-8146 ; 0959-8138 ; 0959-535X ; 1759-2151
    ISSN (online) 1756-1833
    ISSN 0959-8154 ; 0959-8146 ; 0959-8138 ; 0959-535X ; 1759-2151
    DOI 10.1136/bmj.e7264
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: The roles of cytosolic and intramitochondrial Ca

    Rutter, Guy A / McCormack, James G / Halestrap, Andrew P / Denton, Richard M

    The Journal of biological chemistry

    2020  Volume 295, Issue 30, Page(s) 10506

    MeSH term(s) Animals ; Calcium/metabolism ; Calcium Channels/metabolism ; Mitochondria/metabolism ; Oxidative Phosphorylation ; Pyruvic Acid/metabolism
    Chemical Substances Calcium Channels ; Pyruvic Acid (8558G7RUTR) ; Calcium (SY7Q814VUP)
    Language English
    Publishing date 2020-07-24
    Publishing country United States
    Document type Letter ; Comment
    ZDB-ID 2997-x
    ISSN 1083-351X ; 0021-9258
    ISSN (online) 1083-351X
    ISSN 0021-9258
    DOI 10.1074/jbc.L120.013975
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Spatial analysis of tobacco outlet density on secondhand smoke exposure and asthma health among children in Baltimore City.

    Kaviany, Parisa / Senter, James Paul / Collaco, Joseph Michael / Corrigan, Anne E / Brigham, Emily / Wood, Megan / Woo, Han / Liu, Chen / Koehl, Rachelle / Galiatsatos, Panagis / Koehler, Kirsten / Hansel, Nadia / McCormack, Meredith

    Tobacco control

    2022  

    Abstract: ... outlet in a 500 m radius was associated with a 12% increase in air nicotine (p<0.01) and an 8% increase ... in serum cotinine (p=0.01). For every 10-fold increase in air nicotine levels, there was a 0.25-point ... increase in Asthma Therapy Assessment Questionnaire (ATAQ) score (p=0.01), and for every 10-fold increase ...

    Abstract Rationale: Tobacco outlets are concentrated in low-income neighbourhoods; higher tobacco outlet density is associated with increased smoking prevalence. Secondhand smoke (SHS) exposure has significant detrimental effects on childhood asthma. We hypothesised there was an association between higher tobacco outlet density, indoor air pollution and worse childhood asthma.
    Methods: Baseline data from a home intervention study of 139 children (8-17 years) with asthma in Baltimore City included residential air nicotine monitoring, paired with serum cotinine and asthma control assessment. Participant addresses and tobacco outlets were geocoded and mapped. Multivariable regression modelling was used to describe the relationships between tobacco outlet density, SHS exposure and asthma control.
    Results: Within a 500 m radius of each participant home, there were on average six tobacco outlets. Each additional tobacco outlet in a 500 m radius was associated with a 12% increase in air nicotine (p<0.01) and an 8% increase in serum cotinine (p=0.01). For every 10-fold increase in air nicotine levels, there was a 0.25-point increase in Asthma Therapy Assessment Questionnaire (ATAQ) score (p=0.01), and for every 10-fold increase in serum cotinine levels, there was a 0.54-point increase in ATAQ score (p<0.05).
    Conclusions: Increased tobacco outlet density is associated with higher levels of bedroom air nicotine and serum cotinine. Increasing levels of SHS exposure (air nicotine and serum cotinine) are associated with less controlled childhood asthma. In Baltimore City, the health of children with asthma is adversely impacted in neighbourhoods where tobacco outlets are concentrated. The implications of our findings can inform community-level interventions to address these health disparities.
    Language English
    Publishing date 2022-01-19
    Publishing country England
    Document type Journal Article
    ZDB-ID 1146554-2
    ISSN 1468-3318 ; 0964-4563
    ISSN (online) 1468-3318
    ISSN 0964-4563
    DOI 10.1136/tobaccocontrol-2021-056878
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Financial Incentives and Cholesterol Levels.

    Lesser, Lenard I / McCormack, James P

    JAMA

    2016  Volume 315, Issue 15, Page(s) 1657–1658

    MeSH term(s) Cardiovascular Diseases/prevention & control ; Cholesterol, LDL/blood ; Female ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use ; Male ; Medication Adherence ; Motivation ; Patient Participation/economics ; Primary Health Care/economics
    Chemical Substances Cholesterol, LDL ; Hydroxymethylglutaryl-CoA Reductase Inhibitors
    Language English
    Publishing date 2016-04-19
    Publishing country United States
    Document type Comment ; Letter
    ZDB-ID 2958-0
    ISSN 1538-3598 ; 0254-9077 ; 0002-9955 ; 0098-7484
    ISSN (online) 1538-3598
    ISSN 0254-9077 ; 0002-9955 ; 0098-7484
    DOI 10.1001/jama.2016.0309
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Guidelines for treating risk factors should include tools for shared decision making.

    Yudkin, John S / Kavanagh, Jayne / McCormack, James P

    BMJ (Clinical research ed.)

    2016  Volume 353, Page(s) i3147

    MeSH term(s) Blood Pressure ; Decision Making ; Diabetes Mellitus/drug therapy ; Glycated Hemoglobin A/analysis ; Humans ; Life Expectancy ; Patient Participation ; Practice Guidelines as Topic/standards ; Risk Factors
    Chemical Substances Glycated Hemoglobin A ; hemoglobin A1c protein, human
    Language English
    Publishing date 2016-06-14
    Publishing country England
    Document type Journal Article
    ZDB-ID 1362901-3
    ISSN 1756-1833 ; 0959-8154 ; 0959-8146 ; 0959-8138 ; 0959-535X ; 1759-2151
    ISSN (online) 1756-1833
    ISSN 0959-8154 ; 0959-8146 ; 0959-8138 ; 0959-535X ; 1759-2151
    DOI 10.1136/bmj.i3147
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Higher versus lower doses of ACE inhibitors, angiotensin-2 receptor blockers and beta-blockers in heart failure with reduced ejection fraction: Systematic review and meta-analysis.

    Turgeon, Ricky D / Kolber, Michael R / Loewen, Peter / Ellis, Ursula / McCormack, James P

    PloS one

    2019  Volume 14, Issue 2, Page(s) e0212907

    Abstract: Background: Current heart failure (HF) guidelines recommend titrating angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin receptor blockers (ARBs) and beta-blockers (BBs) to target doses used in pivotal placebo-controlled randomized controlled ... ...

    Abstract Background: Current heart failure (HF) guidelines recommend titrating angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin receptor blockers (ARBs) and beta-blockers (BBs) to target doses used in pivotal placebo-controlled randomized controlled trials (RCTs). Despite a number of RCTs comparing different doses (i.e. higher versus lower doses) of ACEIs, ARBs and BBs, the effects of higher versus lower doses on efficacy and safety remains unclear. For this reason, we performed a systematic review and meta-analysis to evaluate the efficacy and safety of higher versus lower doses of ACEIs, ARBs and BBs in patients with HFrEF.
    Methods: We searched MEDLINE, Embase and the Cochrane Central Register of Controlled Trials (CENTRAL) via Ovid from inception to April 25th, 2018 and opentrials.net and clinicaltrials.gov for relevant trials that compared different doses of medications in heart failure. We analyzed trials by drug class (ACEIs, ARBs, and BBs) for efficacy outcomes (all-cause mortality, cardiovascular mortality, all-cause hospitalizations, HF hospitalizations, HF worsening). For safety outcomes, we pooled trials within and across drug classes.
    Results: Our meta-analysis consisted of 14 RCTs. Using GRADE criteria, the quality of evidence for ACEIs and ARBs was assessed as generally moderate for efficacy and high for adverse effects, whereas overall quality for BBs was very low to low. Over ~2-4 years higher versus lower doses of ACEIs, ARBs or BBs did not significantly reduce all-cause mortality [ACEIs relative risk (RR) 0.94 (95% confidence interval 0.87-1.02)], ARBs RR 0.96 (0.87-1.04), BBs RR 0.25 (0.06-1.01)] or all cause hospitalizations [ACEIs relative risk (RR) 0.94 (95% confidence interval 0.86-1.02)], ARBs RR 0.98 (0.93-1.04), BBs RR 0.93 (0.39-2.24)]. However, all point estimates favoured higher doses. Higher doses of ARBs significantly reduced hospitalization for HF [RR 0.89 (0.80-0.99)- 2.8% ARR], and higher doses of ACEIs and ARBs significantly reduced HF worsening [RR 0.85 (0.79-0.92)- 5.1% ARR and 0.91 (0.84-0.99)- 3.2% ARR, respectively] compared to lower doses. None of the differences between higher versus lower doses of BBs were significant; however, precision was low. Higher doses of these medications compared to lower doses increased the risk of discontinuation due to adverse events, hypotension, dizziness, and for ACEIs and ARBs, increased hyperkalemia and elevations in serum creatinine. Absolute increase in harms for adverse effects ranged from ~ 3 to 14%.
    Conclusions: Higher doses of ACEIs and ARBs reduce the risk of HF worsening compared to lower doses, and higher doses of ARBs also reduce the risk of HF hospitalization but the evidence is sparse and imprecise. Higher doses increase the chance of adverse effects compared to lower doses. Evidence for BBs is inconclusive. These results support initially always starting at low doses of ACEIs/ARBs and only titrating the dose up if the patient tolerates dose increases.
    MeSH term(s) Adrenergic beta-Antagonists/administration & dosage ; Adrenergic beta-Antagonists/adverse effects ; Angiotensin Receptor Antagonists/administration & dosage ; Angiotensin Receptor Antagonists/adverse effects ; Angiotensin-Converting Enzyme Inhibitors/administration & dosage ; Angiotensin-Converting Enzyme Inhibitors/adverse effects ; Dose-Response Relationship, Drug ; Female ; Heart Failure/drug therapy ; Heart Failure/physiopathology ; Humans ; Male ; Randomized Controlled Trials as Topic ; Safety ; Stroke Volume ; Treatment Outcome
    Chemical Substances Adrenergic beta-Antagonists ; Angiotensin Receptor Antagonists ; Angiotensin-Converting Enzyme Inhibitors
    Language English
    Publishing date 2019-02-28
    Publishing country United States
    Document type Journal Article ; Meta-Analysis ; Systematic Review
    ISSN 1932-6203
    ISSN (online) 1932-6203
    DOI 10.1371/journal.pone.0212907
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top